POMELLA, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 2.225
AS - Asia 1.082
EU - Europa 771
Continente sconosciuto - Info sul continente non disponibili 231
SA - Sud America 175
AF - Africa 15
OC - Oceania 2
Totale 4.501
Nazione #
US - Stati Uniti d'America 2.137
SG - Singapore 517
IT - Italia 316
RU - Federazione Russa 160
CN - Cina 138
BR - Brasile 137
HK - Hong Kong 126
VN - Vietnam 77
JP - Giappone 64
BD - Bangladesh 55
DE - Germania 52
CA - Canada 45
GB - Regno Unito 45
FI - Finlandia 40
NL - Olanda 34
IE - Irlanda 31
IN - India 26
ID - Indonesia 24
FR - Francia 18
AR - Argentina 15
AT - Austria 14
MX - Messico 12
PL - Polonia 12
IQ - Iraq 10
JM - Giamaica 9
SE - Svezia 9
EC - Ecuador 7
ES - Italia 7
MA - Marocco 7
TR - Turchia 7
LT - Lituania 6
VE - Venezuela 6
CR - Costa Rica 5
GT - Guatemala 5
MY - Malesia 5
PH - Filippine 5
PK - Pakistan 5
ZA - Sudafrica 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
CO - Colombia 4
DK - Danimarca 4
GR - Grecia 4
TT - Trinidad e Tobago 4
CL - Cile 3
IR - Iran 3
TW - Taiwan 3
UZ - Uzbekistan 3
AU - Australia 2
BE - Belgio 2
CZ - Repubblica Ceca 2
EE - Estonia 2
JO - Giordania 2
KE - Kenya 2
LV - Lettonia 2
NI - Nicaragua 2
PR - Porto Rico 2
PS - Palestinian Territory 2
PT - Portogallo 2
AW - Aruba 1
AZ - Azerbaigian 1
CH - Svizzera 1
CI - Costa d'Avorio 1
GD - Grenada 1
HN - Honduras 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MD - Moldavia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SR - Suriname 1
UA - Ucraina 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 4.271
Città #
Singapore 355
Ashburn 259
San Jose 207
Hong Kong 119
New York 104
Council Bluffs 100
Chicago 87
Los Angeles 87
Rome 87
Tokyo 60
Santa Clara 59
The Dalles 59
Buffalo 51
Beijing 49
Dallas 32
Dublin 29
Ho Chi Minh City 27
Denver 25
Moscow 25
Salt Lake City 25
Jakarta 23
Helsinki 22
Tampa 22
Lappeenranta 17
Hanoi 16
Nuremberg 16
Phoenix 16
São Paulo 16
Atlanta 15
North Bergen 15
Elk Grove Village 13
Montreal 13
Orem 13
London 11
Milan 11
Brooklyn 10
Monte Vista 9
Sterling 9
Vienna 9
Warsaw 9
Wilmington 9
Brasília 8
Chennai 8
Frankfurt am Main 8
Miami 8
Mülheim 8
Boston 7
Center 7
Dulles 7
Las Vegas 7
Manchester 7
Munich 7
Naples 7
Seattle 7
Stockholm 7
Da Nang 6
Houston 6
Lancaster 6
Louisville 6
Pittsburgh 6
Toronto 6
Amsterdam 5
Ayn 5
Columbus 5
Guatemala City 5
Kingston 5
Palermo 5
Pasadena 5
Redondo Beach 5
San Francisco 5
San José 5
Washington 5
Bari 4
Belo Horizonte 4
Cincinnati 4
Colorado Springs 4
Detroit 4
Foggia 4
New Delhi 4
Orlando 4
Padua 4
Querétaro 4
Trento 4
Turin 4
Bauru 3
Bismarck 3
Boardman 3
Catania 3
Chesapeake 3
Coccaglio 3
Dortmund 3
Florence 3
Hamilton 3
Jacksonville 3
Johannesburg 3
Lahore 3
Manila 3
Mexico City 3
Monza 3
Mumbai 3
Totale 2.430
Nome #
About a Possible Impact of Endodontic Infections by Fusobacterium nucleatum or Porphyromonas gingivalis on Oral Carcinogenesis: A Literature Overview 221
Epigenetic remodelling in human hepatocellular carcinoma 192
New Insights on the Nuclear Functions and Targeting of FAK in Cancer 154
Radioresistance in rhabdomyosarcomas: much more than a question of dose 133
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies 130
CDK9 as a Valuable Target in Cancer: From Natural Compounds Inhibitors to Current Treatment in Pediatric Soft Tissue Sarcomas 128
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 123
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma 123
KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma 121
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma 120
KDM3B inhibitors disrupt PAX3-FOXO1 oncogenic activity in fusion positive rhabdomyosarcoma 118
MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting 113
PAX3-FOXO1 establishes myogenic super enhancers and confers BET bromodomain vulnerability 113
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 110
Antitumour effects of SFX-01 molecule in combination with ionizing radiation in preclinical and in vivo models of rhabdomyosarcoma 105
Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects 103
Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma 98
MS-275 (Entinostat) Promotes Radio-Sensitivity in PAX3-FOXO1 Rhabdomyosarcoma Cells 98
The Multiple Roles of CD147 in the Development and Progression of Oral Squamous Cell Carcinoma: An Overview 97
FAK Signaling in Rhabdomyosarcoma 95
Dose-dependent activation of gene expression is achieved using CRISPR and small molecules that recruit endogenous chromatin machinery 94
Effects of Angiogenic Factors on the Epithelial-to-Mesenchymal Transition and Their Impact on the Onset and Progression of Oral Squamous Cell Carcinoma: An Overview 92
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 91
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 91
Design of First-in-Class Dual {EZH}2/{HDAC} Inhibitor: biochemical activity and biological evaluation in cancer cells 90
DNMT3A and DNMT3B Targeting as an Effective Radiosensitizing Strategy in Embryonal Rhabdomyosarcoma 90
Romidepsin (FK228) fails in counteracting the transformed phenotype of rhabdomyosarcoma cells but efficiently radiosensitizes, in vitro and in vivo, the alveolar phenotype subtype 89
HDAC3 genetic and pharmacologic inhibition radiosensitizes fusion positive rhabdomyosarcoma by promoting DNA double-strand breaks 82
In vitro and in vivo single-agent efficacy of checkpoint kinase inhibition in acute lymphoblastic leukemia 81
MET inhibition sensitizes rhabdomyosarcoma cells to NOTCH signaling suppression 80
Heat Shock Proteins: Important Helpers for the Development, Maintenance and Regeneration of Skeletal Muscles 80
Chemical genomics reveals histone deacetylases are required for core regulatory transcription 79
Miswired Enhancer Logic Drives a Cancer of the Muscle Lineage 77
SNAI2-mediated repression of BIM protects rhabdomyosarcoma from ionizing radiation 77
Epigenetic determinants of fusion-driven sarcomas: paradigms and challenges 76
Neddylation inhibition induces DNA double-strand breaks, hampering tumor growth in vivo, and promotes radiosensitivity in PAX3–FOXO1 rhabdomyosarcoma 75
The HIV Protease Inhibitor Ritonavir Reverts the Mesenchymal Phenotype Induced by Inflammatory Cytokines in Normal and Tumor Oral Keratinocytes to an Epithelial One, Increasing the Radiosensitivity of Tumor Oral Keratinocytes 74
Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma 73
Small heat-shock protein HSPB3 promotes myogenesis by regulating the lamin B receptor 73
Genomic and Epigenetic Changes Drive Aberrant Skeletal Muscle Differentiation in Rhabdomyosarcoma 69
MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma 68
Inhibition of bromodomain and extra-terminal motif (BET) proteins in pediatric sarcoma: A systematic review of in vitro and in vivo studies 52
The CRISP(Y) Future of Pediatric Soft Tissue Sarcomas 49
Ritonavir and DNA Damage: A New Perspective on an Old Drug 48
Tumor-derived G-CSF induces an immunosuppressive microenvironment in an osteosarcoma model, reducing response to CAR.GD2 T-cells 41
Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer 37
Biological Advances and Current Challenges for Pediatric Rhabdomyosarcoma 27
Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas 26
From bench to bedside: combining HDAC inhibitors with standard therapies in rhabdomyosarcoma treatment 25
Totale 4.501
Categoria #
all - tutte 22.052
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.052


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/2023219 0 0 4 1 0 1 129 11 8 28 31 6
2023/2024144 4 2 6 4 10 52 23 5 7 3 2 26
2024/20251.321 21 215 146 56 9 171 59 41 41 311 205 46
2025/20261.966 158 105 137 179 214 78 217 225 261 137 167 88
2026/2027851 155 83 360 253 0 0 0 0 0 0 0 0
Totale 4.501